Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in ADPKD (SIRENA)
NCT00491517Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Mar 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Total Kidney Volume at 12 months. Started Mar 2007; status: completed.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT00491517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00491517.